Diagnostic impact of RNA-based next-generation sequencing fusion panel for solid tumors: A single-institution experience.

In summary, this study demonstrated the feasibility and utility of an RNA-based NGS fusion panel for a wide variety of solid tumors in the appropriate clinicopathologic context. These findings warrant further validation in larger studies involving multiple institutional patient cohorts.